Keryx Biopharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Keryx Biopharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 90% to $60,641,000. Profit margin reached -270%. Total operating expenses were $137,301,000.
Profit Margin
| 2010 | 0 | 0 | |
|---|---|---|---|
| 2011 | 5M | -28.12M | -562.46% |
| 2012 | 0 | -22.72M | |
| 2013 | 7M | -46.38M | -662.59% |
| 2014 | 10.82M | -111.51M | -1030.19% |
| 2015 | 13.68M | -123.14M | -900.18% |
| 2016 | 31.98M | -161.09M | -503.69% |
| 2017 | 60.64M | -163.44M | -269.52% |
KERX Income Statement (2010 – 2017)
| 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||
Revenue | 60.64M | 31.98M | 13.68M | 10.82M | 7M | 0 | 5M | 0 |
Cost of revenue | 25.03M | 40.68M | 6.64M | 495K | 0 | 0 | 0 | 0 |
Gross profit | 35.61M | -8.70M | 7.03M | 10.33M | 7M | 0 | 5M | 0 |
Operating exp. | ||||||||
Research and development | 37.67M | 29.50M | 36.69M | 51.50M | 34.73M | 19.36M | 27.01M | 13.72M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 137.30M | 114.05M | 118.10M | 121.55M | 54.08M | 27.07M | 33.74M | 21.21M |
Operating income | -101.69M | -122.76M | -111.06M | -111.22M | -47.08M | -27.07M | -28.74M | -21.21M |
Other income (expenses), net | -61.98M | -38.25M | -11.98M | 411K | 351K | 1.71M | -380K | 764K |
Income before tax | -163.67M | -161.01M | -123.05M | -110.81M | -46.73M | -25.36M | -28.36M | 0 |
Income tax expense | -235K | 80K | 90K | 700K | -351K | 0 | 0 | 0 |
Net income | -163.44M | -161.09M | -123.14M | -111.51M | -46.38M | -22.72M | -28.12M | 0 |
Earnings per share | ||||||||
Basic EPS | -1.43 | -1.52 | -1.19 | -1.23 | -0.57 | -0.32 | -0.41 | -0.34 |
Diluted EPS | -1.43 | -1.52 | -1.19 | -1.23 | -0.57 | -0.32 | -0.41 | -0.34 |
| Data source | Data source |